Adam C Carle1. 1. Division of Health Policy and Clinical Effectiveness, Cincinnati Children's Hospital Medical Center, University of Cincinnati Medical School, Cincinnati, OH 45226, USA. adam.carle@cchmc.org
Abstract
BACKGROUND: Accurately understanding treatment effectiveness across heterogeneous populations requires equivalent measurement across the population. Measurement bias refers to the possibility that individuals with identical health respond dissimilarly to questions about their health as a function of their ethnicity or another variable. Without establishing equivalent measurement, the field cannot comparatively evaluate what works best for whom, draw strong conclusions about disparate outcomes, and support evidence-based practice and policy. METHODS: Using data from a representative sample of the 2001-2002 US, the application of multiple-group multiple-indicator, multiple-cause, models to evaluate and correct for measurement bias was described. Analyses investigated whether 10 items operationalizing alcohol abuse provided equivalent measurement across different education and income levels for white (n = 16,480), black/African-American (n = 4139), and Hispanic (n = 4893) individuals. RESULTS: Analyses uncovered a complex pattern of measurement bias across educational attainment, poverty status, and minority status. Ignoring bias, black/African-Americans and Hispanics appeared to have significantly more alcohol abuse-related behavior than whites. After adjusting for bias, whites and Hispanics demonstrated comparable levels of alcohol abuse and black/African-Americans had significantly lower levels of alcohol abuse than whites. CONCLUSIONS: Measurement bias can lead to erroneous conclusions about alcohol abuse across race and ethnicity. This would subsequently bias research that comparatively examines the correlates of alcohol abuse and research that investigates the comparative effectiveness of alcohol abuse treatments across these groups. Using model-based estimates can mitigate errors like these and lead to more accurate conclusions across heterogeneous populations.
BACKGROUND: Accurately understanding treatment effectiveness across heterogeneous populations requires equivalent measurement across the population. Measurement bias refers to the possibility that individuals with identical health respond dissimilarly to questions about their health as a function of their ethnicity or another variable. Without establishing equivalent measurement, the field cannot comparatively evaluate what works best for whom, draw strong conclusions about disparate outcomes, and support evidence-based practice and policy. METHODS: Using data from a representative sample of the 2001-2002 US, the application of multiple-group multiple-indicator, multiple-cause, models to evaluate and correct for measurement bias was described. Analyses investigated whether 10 items operationalizing alcohol abuse provided equivalent measurement across different education and income levels for white (n = 16,480), black/African-American (n = 4139), and Hispanic (n = 4893) individuals. RESULTS: Analyses uncovered a complex pattern of measurement bias across educational attainment, poverty status, and minority status. Ignoring bias, black/African-Americans and Hispanics appeared to have significantly more alcohol abuse-related behavior than whites. After adjusting for bias, whites and Hispanics demonstrated comparable levels of alcohol abuse and black/African-Americans had significantly lower levels of alcohol abuse than whites. CONCLUSIONS: Measurement bias can lead to erroneous conclusions about alcohol abuse across race and ethnicity. This would subsequently bias research that comparatively examines the correlates of alcohol abuse and research that investigates the comparative effectiveness of alcohol abuse treatments across these groups. Using model-based estimates can mitigate errors like these and lead to more accurate conclusions across heterogeneous populations.
Authors: Christopher B Forrest; Katherine B Bevans; Ania Filus; Janine Devine; Brandon D Becker; Adam C Carle; Rachel E Teneralli; JeanHee Moon; Ulrike Ravens-Sieberer Journal: J Pediatr Psychol Date: 2019-10-01
Authors: Christopher B Forrest; Janine Devine; Katherine B Bevans; Brandon D Becker; Adam C Carle; Rachel E Teneralli; JeanHee Moon; Carole A Tucker; Ulrike Ravens-Sieberer Journal: Qual Life Res Date: 2017-08-21 Impact factor: 4.147
Authors: I-Chan Huang; Walter L Leite; Patricia Shearer; Michael Seid; Dennis A Revicki; Elizabeth A Shenkman Journal: Value Health Date: 2011 Sep-Oct Impact factor: 5.725
Authors: Katherine B Bevans; William Gardner; Kathleen A Pajer; Brandon Becker; Adam Carle; Carole A Tucker; Christopher B Forrest Journal: J Pediatr Psychol Date: 2018-07-01
Authors: Adam C Carle; David Cella; Li Cai; Seung W Choi; Paul K Crane; S McKay Curtis; Jonathan Gruhl; Jin-Shei Lai; Shubhabrata Mukherjee; Steven P Reise; Jeanne A Teresi; David Thissen; Eric J Wu; Ron D Hays Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2011-12 Impact factor: 2.217
Authors: Katherine B Bevans; Anne W Riley; Jeanne M Landgraf; Adam C Carle; Rachel E Teneralli; Barbara H Fiese; Lisa J Meltzer; Anna K Ettinger; Brandon D Becker; Christopher B Forrest Journal: Qual Life Res Date: 2017-06-22 Impact factor: 4.147
Authors: Li-Tzy Wu; George E Woody; Chongming Yang; Jeng-Jong Pan; Bryce B Reeve; Dan G Blazer Journal: Int J Methods Psychiatr Res Date: 2012-02-20 Impact factor: 4.035
Authors: Jin-Ah Sim; Geehong Hyun; Todd M Gibson; Yutaka Yasui; Wendy Leisenring; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong; Kevin R Krull; I-Chan Huang Journal: JCO Clin Cancer Inform Date: 2020-01